Histogen (NASDAQ: HSTO) opened its doors in 2007 after heeding to the call of a rising need to develop innovative technologies for aesthetic and therapeutic markets. The discovery by the company’s founder, Dr. Gail Naughton, of the potential of proteins and growth factors produced by cells grown under simulated embryonic […]